Ankle-brachial pressure index for peripheral arterial disease assessment. Indicated for diabetic patients and smokers within the CVD screening programme. Interpretation: > 0.9 normal, 0.41-0.90 mild/moderate PAD, <= 0.40 severe PAD.

Pulse wave velocity (PWV) carotid-femoral measurement for arterial stiffness assessment. Normal value: < 10 m/s. Values >= 10 m/s indicate increased arterial stiffness.

Condition profile for CVD high-risk chronic conditions (e.g. heart failure, CKD).

Records the patient's cardiovascular Screening risk classification, expressed as a percentage value and interpreted using HL7 Observation Interpretation codes.

Care plan for cardiovascular disease prevention within the Lithuanian CVD screening programme. Captures prevention targets (LDL cholesterol, blood pressure, BMI), lifestyle interventions (smoking cessation, diet, physical activity), and follow-up achievement evaluation.

Carotid artery ultrasound for atherosclerotic plaque assessment within CVD screening. Captures plaque categories (none, present, stenosis grades) and intima-media thickness (IMT) for right and left common carotid arteries. IMT > 1.5 mm is considered pathological.

Combined composition for the Lithuanian CVD prevention programme containing all three sections. Use the specific profiles (CvdRiskAssessmentCompositionLtCvd, CvdPreventionPlanCompositionLtCvd, CvdAchievementCompositionLtCvd) when producing individual documents.

Coronary artery calcium score (Agatston method) for CVD risk stratification. Ordered when the need for medication treatment is unclear or the patient does not tolerate statins. Six-level interpretation: 0 (no calcification), 1-10 (minimal), 11-100 (mild), 101-400 (moderate), 401-1000 (significant), > 1000 (very significant).

Anchor resource for the Lithuanian CVD prevention programme document: links a CvdComposition narrative with Observation results (SCORE2, risk group, EKG, etc.). Modelled after the ImagingReport pattern (DiagnosticReport + Composition) but specialised for cardiovascular screening and prevention rather than imaging.

Electrocardiogram (EKG/ECG) observation using 12 leads and SampledData data type.

Echocardiography observation for CVD screening. Captures left ventricular ejection fraction (EF), EF category, and optional established pathology (ICD-10).

Generic structure for recording Screening-related risk factors, such as hypertension, diabetes, or dyslipidemia. Captures both the assessed risk probability and the treatment status.

SCORE2 (Systematic Coronary Risk Estimation) cardiovascular disease risk assessment estimate.

Cardiovascular disease risk classification for the patient (Large or Very large).

Interpretation categories for ankle-brachial index (ABI) peripheral arterial disease severity.

Interpretation of pulse wave velocity (PWV) carotid-femoral measurement: normal (< 10 m/s) or increased (>= 10 m/s).

Concepts representing codes used in Cvd Composition.

ICD-10 codes representing conditions that significantly increase cardiovascular disease risk, often used for risk stratification in Screening programs.

Degree of cardiovascular disease risk according to SCORE2 risk estimation table.

Defines the interpretation categories for cardiovascular disease risk assessment results, based on HL7 Observation Interpretation codes.

Categories for atherosclerotic plaque assessment in carotid arteries.

Six-level interpretation scale for coronary artery calcium (Agatston) score.

SNOMED CT codes for interpreting electrocardiogram (EKG/ECG) findings within the Lithuanian CVD screening programme. Includes both high-level interpretation (normal/abnormal) and specific finding codes. Multiple findings may be recorded simultaneously (e.g., abnormal + atrial fibrillation). Free-text "Other" findings should be captured in Observation.note.

Categories for left ventricular ejection fraction (LVEF) classification.

SNOMED CT concepts representing screening-related risk factors within the Lithuanian CVD screening programme. Central obesity is assessed based on waist circumference (WaistCircumference profile from LT VitalSigns): men >= 102 cm, women >= 88 cm.

Component codes for ankle-brachial index observations (laterality).

Interpretation categories for ankle-brachial index (ABI) peripheral arterial disease severity.

Stable linkId values for the illustrative ESPBI form 2 Questionnaire; used as ConceptMap source codes.

Target codes for ConceptMap rows: Lithuanian programme StructureDefinitions and related profiles referenced from ESPBI Questionnaires.

Stable linkId values for the illustrative ESPBI form 1 Questionnaire; used as ConceptMap source codes.

Categories for atherosclerotic plaque assessment in carotid arteries.

Component codes for carotid artery ultrasound observations (plaque and IMT, laterality).

Six-level interpretation scale for coronary artery calcium (Agatston) score.

Categories for left ventricular ejection fraction (LVEF) classification.

Maps ESPBI form 2 Questionnaire linkIds to Lithuanian FHIR profiles and related IGs. Human-readable narrative is in each target.comment. Source: linkId codes; target: profile identifiers (CodeSystem cvd-questionnaire-mapping-target).

Maps ESPBI form 1 Questionnaire linkIds to Lithuanian FHIR profiles and related IGs. Human-readable narrative is in each target.comment; Questionnaire.item.definition repeats canonical StructureDefinition URIs where applicable. Source: linkId codes; target: profile identifiers (CodeSystem cvd-questionnaire-mapping-target).

Aligned with DSTU1 data structures.

In DSTU1, the CarePlan used inline <goal> elements with extensions for target values and <activity> elements for lifestyle interventions. In R5:

• Goals are referenced via CarePlan.goal pointing to standalone Goal resources (or contained inline). Goal types: LDL target, BP target, BMI target, weight loss ≥5%.
• Activities use CarePlan.activity.plannedActivityReference for structured references or CarePlan.activity.performedActivity for completed activities.
• Risk group moved from DSTU1 inline Observation to an extension on CarePlan.
• Informational text (healthy nutrition, healthy weight, regular medication) is carried in CarePlan.note or CarePlan.supportingInfo.display.

An example instance of a CarePlan for a patient at risk of Cardiovascular Disease (CVD), covering goals and activities related to lifestyle changes.

Plan of care with LDL, BP, smoking cessation, diet, physical activity, BMI goals. Migrated from DSTU1.

Care plan goals with achievement status. Migrated from DSTU1.

CVD screening plan for a patient at high cardiovascular risk, where goals are separate Goal resources referenced by the CarePlan.

CVD screening plan for a patient at high cardiovascular risk, including goals, risk group, lifestyle recommendations and medication instructions.

CVD questionnaire/plan narrative composition: local CVD profiles plus Base, VitalSigns, Lab, Lifestyle analogue examples per mapping.md.

Synoptic CVD prevention document with assessment (risk and findings), prevention plan (CarePlan), and achievement evaluation (follow-up observations).

ŠKL prevencijos priemonių planas. Migrated from DSTU1 SKL02.

ŠKL prevencijos priemonių plano pasiekimų vertinimas. Migrated from DSTU1 SKL03.

Example composition mirroring SKL01 XML structure; references migrated skl01 instances.

ŠKL rizikos vertinimas. Migrated from DSTU1 SKL01.

Example instance showing a patient with a high-risk condition of heart failure.

Minimal stub for the DSTU1 chronic disease referenced in the SKL01 diagnosis list.

Example DiagnosticReport anchoring the CVD composition and listing all Observations included in the programme document (assessment and achievement).

Minimal stub for the DSTU1 encounter referenced by SKL01/02/03 migration composition examples.

Target BP 120–129/<80 mmHg.

Target BMI 22.5 kg/m² (healthy weight range 18.5–24.9).

Target LDL Cholesterol < 1.8 mmol/L.

ŠKL rizikos veiksniai. Migrated from DSTU1 cid:18cvd.

Rizikos veiksniai. Migrated from DSTU1 cid:18espbi.

Prescription medications list. Migrated from DSTU1 cid:3disp.

Hospital discharge diagnosis note list. Migrated from DSTU1 cid:2.

Non-prescription medications. Migrated from DSTU1 cid:3stmt.

Minimal stub for the DSTU1 medication referenced in the SKL01 MedicationStatement.

Minimal stub for the DSTU1 dispensed medication referenced in the SKL01 medications-dispensed list.

Non-prescription medication. Migrated from DSTU1 cid:32.

Example instance of a MedicationStatement for screening programs.

Alkoholio vartojimas. Migrated from DSTU1 cid:189.

KMI 26.23 kg/m2. Migrated from DSTU1 cid:196.

Body mass index 29.1 kg/m2. Migrated from DSTU1 cid:11.

Sistolinis ir diastolinis kraujospūdis. Migrated from DSTU1 cid:197.

Blood pressure systolic and diastolic. Migrated from DSTU1 cid:8.

Body height 188 cm. Migrated from DSTU1 cid:8.

Body height 176 cm. Migrated from DSTU1 cid:9.

Kūno svoris 76 kg. Migrated from DSTU1 cid:9.

Body weight 90 kg. Migrated from DSTU1 cid:10.

Example showing a patient assessed as having a 24% cardiovascular disease risk, categorized as High.

Širdies ir kraujagyslių ligų rizikos grupė – High. Migrated from DSTU1 cid:1104.

Annotation comment. Migrated from DSTU1 cid:4.

Example showing a patient who has had Diabetes Mellitus for more than 10 years.

Example showing a patient with confirmed diabetes mellitus but not yet receiving treatment.

Ar CD > 10 metų? Migrated from DSTU1 cid:184.

Cukrinis diabetas – Yra. Migrated from DSTU1 cid:183.

Kraujospūdis: diastolinis 60 mm[Hg]. Migrated from DSTU1 cid:1981.

Diastolic blood pressure 84 mm[Hg]. Migrated from DSTU1 cid:82.

Mityba. Migrated from DSTU1 cid:188.

Example showing a patient with confirmed dyslipidemia currently under lipid-lowering therapy.

Dislipidemija – Yra. Migrated from DSTU1 cid:182.

Example of a normal 12-lead EKG recording with sampled waveform data.

Automatiniai skaičiavimai/vertinimai. Migrated from DSTU1 cid:110.

Example follow-up LDL measurement for achievement evaluation (CVD prevention programme).

Example follow-up systolic/diastolic blood pressure for achievement evaluation.

Širdies susitraukimų dažnis 72 bpm. Migrated from DSTU1 cid:199.

Example showing a patient with negligible risk for hypertension; treatment not indicated.

Hipertenzija – Yra. Migrated from DSTU1 cid:181.

Example showing a patient identified with impaired glucose tolerance or impaired fasting glycemia.

Gliukozės tolerancijos sutrikimas – Yra. Migrated from DSTU1 cid:185.

MTL cholesterolis 2.8 mmol/L. Migrated from DSTU1 cid:1915.

LDL cholesterol 1.7 mmol/L. Migrated from DSTU1 cid:7 (medicinosnk.lt code 39469-2).

Laboratoriniai tyrimai. Migrated from DSTU1 cid:191.

Laboratory studies set with LDL result. Migrated from DSTU1 cid:14.

Metabolinis sindromas – No. Migrated from DSTU1 cid:1102.

Diagnosis recommendations narrative. Migrated from DSTU1.

Antsvoris arba nutukimas – Yra. Migrated from DSTU1 cid:193.

Fizinis aktyvumas. Migrated from DSTU1 cid:187.

Bendras ŠKL rizikos vertinimas 20%. Migrated from DSTU1 cid:1103.

Example of SCORE2 risk assessment showing 24% estimated risk (high).

Rūkymas. Migrated from DSTU1 cid:186.

Kraujospūdis: sistolinis 107 mm[Hg]. Migrated from DSTU1 cid:1971.

Systolic blood pressure 132 mm[Hg]. Migrated from DSTU1 cid:81.

Bendras cholesterolis. Migrated from DSTU1 cid:1912.

Yra ir gydoma. Migrated from DSTU1 cid:18treatment.

Gliukozė veniniame kraujyje 15 mmol/L. Migrated from DSTU1 cid:1910.

Vital signs note panel. Migrated from DSTU1 cid:19.

Vital signs note panel with members. Migrated from DSTU1 cid:6.

Liemens apimtis 103 cm. Migrated from DSTU1 cid:194.

Body weight at first visit 95 kg. Migrated from DSTU1 cid:12.

Example of a healthcare organization

An example Patient conforming to the Lithuanian Base Profile.

An example Practitioner conforming to the Lithuanian Base Profile.

An example PractitionerRole linking a practitioner to an organization.

Illustrative FHIR Questionnaire for the CVD prevention measures plan and achievement evaluation electronic form (PDF table 10.10+). Extend with full national field parity in production.

Illustrative FHIR Questionnaire for the national patient cardiovascular disease risk assessment electronic form (PDF tables 10.5–10.9). Extend with full field parity in production.

Example answers for the prevention plan Questionnaire including a follow-up achievement block.

Example answers for the CVD risk assessment Questionnaire, aligned with other CVD IG examples (SCORE2 24%, high risk group).